What Women Can Do to Take Control of Their Reproductive Health & Rights Post-Roe, according to Mary Jane Minkin, M.D.
Retrieved on:
Mittwoch, April 17, 2024
Women, FDA, Baby, Maternity, Convenience Store, Health, Consumer, Pharmaceutical, General Health, Retail, Education, Medroxyprogesterone acetate, Roe v. Wade, 7-Eleven, LARC, Misoprostol, Condom, Safety, Pregnancy, Woman, Cadence, Policy, Supreme court, OTC, Mini, Planned Parenthood, Mifepristone, Reproductive rights, Abortion, Uterus, Yale University, Arm, Birth, Parenthood, Reproductive Sciences, Long-acting reversible contraceptives, Confidentiality, Progesterone, Pharmacy, Birth control
Mary Jane Minkin, M.D., Clinical Professor of Obstetrics, Gynecology, and Reproductive Sciences at Yale University, stresses the critical need for accessible contraception and reproductive health tools to prevent unintended pregnancies.
Key Points:
- Mary Jane Minkin, M.D., Clinical Professor of Obstetrics, Gynecology, and Reproductive Sciences at Yale University, stresses the critical need for accessible contraception and reproductive health tools to prevent unintended pregnancies.
- "The rollback on reproductive rights makes it absolutely imperative that we prioritize comprehensive access to contraception," says Dr. Minkin.
- "It's not just about preventing pregnancy; it's about preserving the autonomy and health of women across the nation."
- "We must ensure that women of all ages have the education, resources, and confidentiality to make informed choices about their reproductive health.